
ADAMAS PHARMACEUTICALS INC
Share · US00548A1060 · ADMS · A111X7 (XNAS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 175,84 % |
Company Profile for ADAMAS PHARMACEUTICALS INC Share
Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. The company offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. It is also developing ADS-5102 that is in Phase III clinical study to treat walking impairment in patients with multiple sclerosis and other indications; and ADS-4101, which has completed two Phase I studies for treating partial onset seizures in patients with epilepsy. In addition, the company offers Namzaric (memantine hydrochloride extended release and donepezil hydrochloride) capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Emeryville, California.
Company Data
Name ADAMAS PHARMACEUTICALS INC
Company Adamas Pharmaceuticals, Inc.
Symbol ADMS
Website
http://www.adamaspharma.com
Primary Exchange
NASDAQ

WKN A111X7
ISIN US00548A1060
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Neil McFarlane
Country United States of America
Currency USD
Employees 0,1 T
Address 1900 Powell St Ste 1000, 94608 Emeryville
IPO Date 2014-04-10
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | ADMS |
More Shares
Investors who ADAMAS PHARMACEUTICALS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.